Manager, Corporate FP&A Business Partner at Legend Biotech

Franklin Township, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

Bachelor’s degree in Finance, Accounting, Economics, or related field
5+ years of experience in FP&A or financial business partnering
Strong understanding of financial statements and business drivers
Excellent communication and presentation skills
Strong proficiency in financial planning tools (e.g., Anaplan, OneStream, SAP Analytics)
Proficiency in Excel, PowerPoint, and financial planning tools
Ability to manage multiple priorities and deliver high-quality insights under tight deadlines

Responsibilities

Partner with business units finance teams to support budget and forecast submissions
Coordinate calendar and deliverables for planning cycles (budget, forecast, long-range plan)
Develop clear, insightful financial commentaries for leadership reviews
Prepare monthly and quarterly business review presentations for senior leadership
Analyze financial performance and variances across departments and regions
Act as a strategic advisor to business units on financial planning and decision-making
Translate complex financial data into actionable insights for non-financial stakeholders
Contribute to strategic initiatives by modeling scenarios and evaluating financial impact
Support ad hoc analysis and special projects for executive stakeholders

Skills

FP&A

Budgeting

Forecasting

Variance Analysis

Financial Modeling

Business Partnering

Financial Analysis

Leadership Presentations

Long Range Planning

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free